Endometriosis

New England CEPAC

ICER will review elagolix (AbbVie) for management of endometriosis with associated pain.

Associated Meetings

July 12, 2018 10am - 4pm ET

Champlain College
Communication & Creative Media (CCM) Building
375 Maple Street
Burlington, VT 05401

The New England CEPAC will review ICER's report on elagolix for endometriosis.


Key Dates

Associated Materials

12/14/2017 – 01/08/2018

01/11/2018

01/11/2018 – 02/01/2018

01/11/2018

02/09/2018

03/16/2018

03/16/2018

05/04/2018

Open to public comment until May 31, 2108. For more information on submitting a public comment, please visit our stakeholder engagement page.


05/04/2018 – 05/31/2018
Public Comments

05/04/2018

06/15/2018
Evidence Report

06/15/2018
Revised Voting Questions

06/15/2018
Response to Comments

07/12/2018
Meeting Agenda

07/27/2018
Final Evidence Report and Meeting Summary